The subcellular distribution of ('H)-styrene-7,8-oxide was studied in the rat liver. The compound was added to liver homogenate to give a final concentration of 2 x lo-'; 2 x lo-' and 2 x lo-' M. Subcellular fractions were obtained by differential centrifugation. Most of styrene oxide (59-88%) was associated with the cytosolic fraction. Less than 15 percent of the compound was retrieved in each of the nuclear, mitochondria1 and microsomal fractions. A considerable percentage of radioactivity was found unextractable with the organic solvents, suggesting that styrene oxide reacted with the endogenous compounds. The intracellular distribution of this epoxide was also studied in the perfused rat liver. Comparable results with those previously described were obtained. The binding of styrene oxide to the cytosolic protein was investigated by equilibrium dialysis and ultrafiltration. Only a small percentage of the compound was bound to protein. 26. Ota I;. Hammock BD 11980): Cytosolic and micro-soma1 epoxide hydrolases: differential properties in mammalian liver. Science 207:1479-1481. 27. Gill SS. Hammock BD (1980): Distribution and properties of mammalian soluble styrene oxidehydroxylase. Biochern. Pharrnacol. 29:389-395. 28. Hosegawa LS, Hammock RD (1982): Spectrophotometric assay for mammalian cytosolic epoxide hydrolase using trans-stylbene oxide as thc substrate.
INTRODUCTION
Styrene oxide, a carcinogenic (1) mutagenic and teratogenic (2) epoxide, has often been used as a substrate to measure the activities of its detoxicating enzymes: epoxide hydrolase and glutathione S-transferase. These enzymes reside in different cellular structures. The epoxide hydrolase is mainly associated with the microsomal and glutathione S-transferase with the cytosolic fraction in rat (3) monkey (4) and human (5, 6 ) liver. The relationship between the compartmentation of the epoxide metabolizing enzymes and the detoxication capacity of a tissue has recently been discussed (7) . The intracellular distribution of drugs is considered to be'dependent upon their chemical structures (&9, 1 0 , l l ) .
Data on the intracellular distribution of an epoxide have not been published. Thus, we Prescntcd at the Second International Symposium Sponsored by the Universities of Sassari and Cagliari. Session Ill: "Xletabolisni of Chcmical Carcinogens and Sequential Analysis", October 12-15. 1983. Alghero. Italy. This Symposium scction will be continued in Volume 12. Number 2. 1984 investigated the intracellular distribution of styrene oxide in rat liver.
METHODS
Chemicals: (7-3H)-styrene-7,8-oxide (99.6 mCi/mmol, purity better than 99%) was purchased from The Radiochemical Center (Amersham, England). Unlabelled styrene oxide and styrene glycol were obtained from Aldrich (Beerse, Belgium). PPO, POPOP and Triton X-100 were obtained from Sigma (St. Louis, Mo, USA). TLC plates (19 channels, LK5DF coated with silica gel) were purchased from Whatman Inc. (Clifton, NJ, USA). Hexane, toluene, methylene chloride and ethanol were of the highest purity available, and purchased from Carlo Erba (Milan, Italy). Labelled and unlabelled styrene oxide were purified prior to use as previously reported (12) .
Animals: Female Sprague-Dawley rats, 160-180 g, with free access to water and food, were used.
In vitro distribution: Six rats were used for each experimental point. Animals were PACIFICI, CUOCI AND KANE TOXICOLOGIC PATHOLOGY killed by decapitation. The liver was quickly removed and immediately minced in ice-cold 0.25 M sucrose (pH 7.4 with Tris). Aliquots of liver (0.5 g) were homogenized in 10 volumes of ice-cold 0.25 M sucrose (pH 7.4, Tris) using a glass-teflon homogenizer (Thomas, Philadelphia, Pa, USA). The clearance between glass and pestle was 0.15-0.23 mm. Labelled and unlabelled styrene oxide were mixed and added to the homogenizer to give a final concentration of 2 x lo+; 2 x and 2 x M and a constant amount of radioactivity of 6.5 pCi. Subcellular fractions were obtained by differential centrifugation as previously described (11) . Each pellet was immediately resuspended in 4 ml ice-cold 0.25 M sucrose containing 5 mM unlabelled styrene oxide as carrier. Aliquots (0.5 mi) of each fraction were treated with NaOH to digest the protein and 10 ml of scintillation mixture were then added. Samples were kept at 4°C for 1 day in order to eliminate fluorescence and the radioactivity was then measured in a liquid scintillation system. The cpm were converted into dpm and the results were referred as total radioactivity.
A second aliquot (1 ml) of each fraction was immediately transferred to a tube containing 0.5 ml ethanol and then extracted with hexane as previously reported (13) . One ml of the hexane phase was added to 10 ml of scintillation mixture. The cpm were converted into dpm and the results were referred as "styrene oxide". The recovery of styrene oxide in the hexane phase was measured for each fraction. After 3 extractions the recovery ranged between 96.8 k 0.3% (soluble fraction) and 98.2 +-0.2% (mitochondria1 fraction). Most of the compound was extracted with the first extraction. The eventual presence of styrene glycol in the hexane extracts was checked in a pilot experiment. An aliquot of the extract containing unlabelled styrene glycol as carrier was chromatographyed on a TLC plate (14) .
A third aliquot (0.5 ml) of each fractiog was transferred to 5 ml of methylene chlorideand extracted by vortexing for 5 min. A second extraction with this solvent or with ethyl acetate was found unnecessary. An aliquot (0.1 ml) of the clear water phase residue was added to 10 ml of scintillation mixture and the radioactivity was counted. The cpm were converted into dpm and the results were referred as "unextractable radioactivity".
Distribution in perfused liver: Six rats were anesthetized with ether. The liver was exposed by a midline incision and the porta and cava veins were cannulated. The livers were then perfused in situ as described elsewhere (15) . The organs were first perfused for 10 min (single circulation, constant flow of 15 ml/min) with oxigenated Krebs-Ringer buffer containing glucose and albumin (13) . 'The temperature (37°C) and the pH (7.4) of the buffer were kept constant throughout the experiment. The livers were then perfused as previously described with 50 ml of buffer containing 2 mM 3H-styrene oxide (13.1 pCi). At the end of the perfusion, the radioactive medium still present in the liver was flushed away with 10 ml of ice-cold buffer. The largest hepatic lobe was immediately removed and frozen in liquid nitrogen. Aliquots (0.5 g) were homogenized in 10 volumes of ice-cold 0.25 M sucrose (pH 7.4 with Tris) containing 5 mM of unlabelled styrene oxide as carrier. Subcellular fractions were obtained and treated as previously described.
Binding Study:
Equilibrium dialysis: Aliquots (0.5 ml) of fresh rat liver cytosol were placed in a 0.5 cm diameter visking tube with pore diameter 24 Angstrom (Union Carbide Corp., Chicago, Ill., USA) that had been soaked overnight with 0.13 M ortophosphate buffer (pH 7.4). Samples were dialyzed against 20 ml of orthophosphate buffer for 2-8 h at 0-2"C with continuous shaking. Incubations were started by the addition to the medium of 3H-styrene oxide (3 pCi) to give a final concentration of styrene oxide of 0.2 mM. The spontaneous hydration of styrene oxide in the buffer was studied and was found to be 0.072% in 4 h when the temperature was 0-2°C. Aliquots (0.3 ml) of both buffer and cytosol were sampled at the scheduled time and transferred to a tube containing 0.7 ml of water, 0.5 ml of ethanol and unlabelled styrene oxide (as carrier) to give a final concentration of 5 mM. Samples were then extracted with hexane as previously described and aliquots (I ml) of the organic phase were used to measure the radioactivity.
Ultrafiltration: An aliquot of 3H-styrene oxide was added to 5 mI of ice-cold fresh rat liver cytosol to give a final concentration of 0.2 miM. The samples were transferred to ultrafilters (Amicon Centriflow ultrafilters CF-50, Amicon Corp. Lexington, Mass, USA) and centrifuged at 800 x g for 10 min in a at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from refrigerated centrifuge (4°C). Aliquots (0.1 ml) of the original or ultrafiltered cytosol were added to 0.9 ml water and 0.5 ml ethanol containing styrene oxide (as carrier) to give a final concentration of 5 mM. The samples were extracted with hexane as previously described and the radioactivity measured in 1 ml of the organic phase.
Protein concentrations were measured by the Lowry method (16).
Radioactivity: The liquid scintillation cocktails were prepared according to Turner (17) . The radioactivity in the acqueous phase (total volume of water was kept constant at 1.0 ml) was measured after addition of 10 ml of the system A (see below) whereas the radioactivity in the organic phase was measured using 10 ml of system B. Counting efficiency ranged from 26 to 31% with system A and was 51% with system B.
System A contained 1 1 toluene, 0.5 1 Triton X-100,5 g 2,5-diphenyloxazole (PPO) and 0.1 g 2,2-p-phenylene-bis (5-phenyloxazole) (PO-POP). System B was similar to system A but Triton X-100 was omitted.
Statistical analysis: The statistical comparison between fractions of the same liver was made using student's t test for paired data.
RESULTS
The subcellular distribution profile of 3Hstyrene oxide was studied after addition of the compound fo rat liver homogenates (Figure 1) . Most of the total and unextractable radioactivity as well as the authentic styrene oxide were associated with the cytosolic fraction. Consistent results were obtained when the distribution of styrene oxide was based on mg protein ( Figure Id 
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The binding of styrene oxide to cytosolic protein was measured by equilibrium dialysis and ultrafiltration, both performed at 0 to 4°C. Results are shown in 
DISCUSSION
The present data show that most of styrene oxide present in the rat liver is associated with the cytosolic fraction. Less than 15 percent of this compound is retrieved from each of the nuclear, mitochondrial and micro-soma1 fractions.
The distribution of drugs within cellular structures is a complex phenomenon governed by both the tissue features ("affinity for" or "binding to") and the physico-chemical properties of drug molecules, such as ionization and lipid solubility (8, 9, 11, 18 ). The information on subcellular distribution of drugs is sparse, and most of the studies involve non-hepatic tissues (8, 9, 10, 11, 19, 20, 21, 22, 23, 24, 25) . This makes it difficult to compare the present results with earlier studies. However, a preferential drug accumulation in the cytosol has been described for ethorphine in rat brain (lo), mescaline in mouse brain (20) , benzoic acid and phenobarbital in rat adrenal medulla (8) dichlorodiamineplatinum in rat liver and kidneys (19) and Arsenazo in rabbit skeletal muscle (22) .
When 3H-styrene oxide is added to ice-cold rat liver homogenate a portion of the radioactivity becomes unextractable. The epoxide thus binds to the endogenous compounds. This reaction presumably occurs with molecules bearing thiol groups such as glutathione, since the formation of radioactive thioether conjugates was demonstrated by perfusing the rat liver (3, 13) with labelled styrene oxide. The amount of unextractable radioactivity in the homogenate increased with increasing concentration of styrene oxide. In contrast, the conjugated to total radioactivity ratios follow a reverse relationship. This could indicate that a large part of styrene oxide may become available to metabolic sites and toxicologic targets. In fact, the metabolism and toxicity of styrene oxide was found concentration-dependent in perfused rat liver (13) . The finding of minimal accumulation of styrene oxide in various subcellular particles and its limited binding to cytosolic protein suggests that the intracellular distribution pattern of this epoxide may be governed more by its chemico-physicaI properties than by the biological features of the liver. This is also supported by the experiments with the perfused liver.
Styrene oxide is biotransformed to styrene glycol by epoxide hydrolase, and conjugated to glutathione by glutathione S-transferase. The subcellular distribution of these enzymes was studied with styrene oxide in monkey (4) and human (5, 6) liver. Epoxide hydrolase is mainly confined to the particulate fraction, primarily to the microsomes, whereas glutathione S-transferase is found in the cytosolic fraction only. The balance between the two metabolic pathways is determined by their relative enzymatic activities, the affinity of the enzymes for the substrate and its concentration at the metabolic sites (7). The present report shows that most of styrene oxide is available to glutathione Stransferase, being confined largely to the cytosol.
Other .epoxides such as trans-methyl styrene oxide and ally1 benzene oxide (26), ethylene oxide (27) and trans-stilbene oxide (28) are preferentially hydrated by the cytosolic hydrolase. It would be of interest to determine if such epoxides have an intracellular distribution pattern similar to that of styrene oxide.
